Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
Therapy Areas
Cardiovascular Metabolic
Bone Health
Inflammation
Oncology
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research & Development Strategy
Overview
Human & Disease Biology
Novel Targets & Modalities
Clinical Trial Optimization
AI & Data Science
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
Overview
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2024 Sustainability Highlights Report
Environment, Social and Governance Strategy
Healthy People
Overview
Access to Healthcare
Health Equity
Healthy Society
Overview
Diversity, Inclusion and Belonging
Human Capital Management
Community Investment and Amgen Foundation
Supplier Diversity
Healthy Planet
Overview
Environmental Sustainability
Supplier Sustainability
Healthy Amgen
Overview
Corporate Governance
Business Ethics and Compliance
Ethical Research and Development
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Overview
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Newsroom
Partners
Investors
Careers
Amgen Worldwide
Overview
Research & Development Strategy
Overview <i class="fa fa-external-link"></i>
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
Scientific Community Initiatives
Manufacturing
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Therapy Areas
General Medicine
Rare Disease
Inflammation
Oncology
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research & Development Strategy
Human & Disease Biology
Novel Targets & Modalities
Clinical Trial Optimization
AI in Research & Development
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
2024 Sustainability Highlights Report
Corporate Sustainability Strategy
Healthy People
Access to Healthcare
Health Equity
Healthy Society
Amgen Foundation and Community Investment
Diversity, Inclusion and Belonging
Human Capital Management
Supplier Diversity
Healthy Planet
Environmental Sustainability
Supplier Sustainability
Healthy Amgen
Corporate Governance
Business Ethics and Compliance
Ethical Research and Development
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
Science and Innovation
>
Science and Innovation Stories
AMGEN
05.02.2025
$name
Read more
All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
AMGEN
05.02.2025
$name
SCIENCE & INNOVATION
05.02.2025
Robots of Amgen
SCIENCE & INNOVATION
04.24.2025
Driving Drug Design Using DNA Encoded Libraries
SCIENCE & INNOVATION
04.17.2025
Follow the Data
SCIENCE & INNOVATION
04.09.2025
Unlocking Disease: Amgen’s Omics Approach Advances Targeted Treatments
SCIENCE & INNOVATION
04.08.2025
45 Years of Amgen
SCIENCE & INNOVATION
04.03.2025
First FDA Approval of Its Kind for People Living With IgG4-Related Disease
SCIENCE & INNOVATION
02.11.2025
Breaking Barriers: From Farm to Pharma
SCIENCE & INNOVATION
01.24.2025
North Carolina Ribbon Cutting Marks Important Milestone in Expansion to Meet Growing Demand for Amgen Medicines
SCIENCE & INNOVATION
01.21.2025
Cracking Cholesterol: Biology-Driven Breakthrough Wins Rathmann Award
SCIENCE & INNOVATION
12.12.2024
Ten Years of BLINCYTO
®
(blinatumomab): Celebrating the History, Impact and Future
SCIENCE & INNOVATION
12.11.2024
Amgen's Nobel Laureate Network: A Catalyst for Innovation
Load more
Loading...
Otomatik - 108.157.4.113
CloudFlare DNS
Türk Telekom DNS
Google DNS
Open DNS
OSZAR »
